China unveiled a plan to elevate the food and drug regulator to a ministry-level body with broader powers, underpinning the government’s pledge to crack down on safety violations and better protect consumers.
China ordered nationwide inspections of preserved-egg plants after media reports that toxic chemicals are being used as additives, the latest in a series of food scandals that have plagued the world’s most populous nation.
Merck & Co., Novo Nordisk A/S and other makers of popular treatments for diabetes may be asked to collect more data on a potential cancer link even as they try to reassure U.S. regulators this week of the drugs’ safety.
Half of the 21 drugs pulled from the market in the U.S. for safety reasons since 1995 involved heart complications, a finding that is spurring Congress and doctors to call for closer government review of side effects.
Hemofarm AD, a Serbian drugmaker owned by Stada Arzneimittel AG, said it fixed contamination threats in its aseptic production line found by the U.S. Food and Drug Administration, which halted its exports to the U.S.
A former U.S. Food and Drug Administration official said GlaxoSmithKline Plc withheld from regulators a study showing its Avandia diabetes drug may cause heart attacks, according to two people familiar with her deposition in a lawsuit against the drugmaker.